Africa Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: A 6-Country Analysis-Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

March 2023 | | ID: AE3E6B227AF1EN
Venture Planning Group

Abstracts

This new six-country report explores business and technological trends; provides test volume and sales forecasts for 40 hemostasis procedures; compares features of major analyzers; profiles leading market players and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

The report explores business and technological trends; provides test volume and sales forecasts for 40 hemostasis procedures; compares features of major analyzers; profiles leading market players and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Rationale

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation diagnostics practice during the next five years.

New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

Coagulation Tests Analyzed in the Report

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Country Analyses

Egypt, Ghana, Kenya, Morocco, Nigeria, South Africa

Competitive Assessments

Extensive strategic profiles of major suppliers and emerging market entrants.

Current and Emerging Products

• Review of established and emerging procedures.
• Comparison of automated and semi-automated analyzers marketed by Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review

• Analysis of current and emerging technologies and their potential market applications.
• Companies developing or marketing new technologies and products by test.

Strategic Recommendations

• Product development and business expansion opportunities with significant market appeal.
• Ideal product models with tentative prices and operating characteristics.
• Alternative market penetration strategies for instrument and reagent suppliers.
• Potential market entry barriers and risks.

Contents

I. INTRODUCTION

II. MARKET OVERVIEW

III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

V. ALTERNATIVE MARKET PENETRATION STRATEGIES

VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

VII. MARKET AND TECHNOLOGY OVERVIEW

A. Major Routine and Special Coagulation Tests
  1. Introduction
  2. Activated Partial Thromboplastin Time (APTT)
  3. Alpha-2 Antiplasmin
  4. Antithrombin III
  5. Bleeding Time
  6. D-Dimer
  7. Ethanol Flocculation Test
  8. Euglobulin Lysis
  9. Factor Assays
    a. Introduction
    b. Factor II
    c. Factor V/Factor V Leiden
    d. Factor VII
    e. Factor VIII
    f. Factor IX
    g. Factor IXa
    h. Factor X (Stuart Factor)
    i. Factor Xa
    j. Factor XI
    k. Factor XII
    l. Factor XIII
  10. Fibrin Degradation Products
  11. Fibrinogen
  12. Heparin
  13. Hirudin
  14. Hypercoagulability and Thrombosis
  15. Lipoprotein a
  16. Plasmin
  17. Plasminogen
  18. Plasminogen Activator Inhibitor (PAI)
  19. Platelet Function Tests
  20. Platelet Aggregation
  21. Proteins C and S
  22. Prothrombin Fragment 1.2
  23. Prothrombin Time (PT)
  24. Reptilase Time
  25. Thrombin Time
  26. Tissue-Type Plasminogen Activator (t-PA)
  27. Von Willebrand's Factor
B. Coagulation Instrumentation Review: Centralized And POC Testing Analyzers
C. Major Coagulation Testing Technologies And Their Potential Applications

VIII. COUNTRY MARKET ANALYSES: MARKET SIZE, REAGENT AND INSTRUMENT SALES FORECASTS, VOLUME PROJECTIONS FOR 40 PROCEDURES, SUPPLIER SALES AND MARKET SHARES

Egypt
Ghana
Kenya
Morocco
Nigeria
South Africa

IX. COMPETITIVE ASSESSMENTS

The report provides strategic assessments of over 20 leading coagulation market players and start-up companies with innovative technologies and products, including:
  Abbott
  Beckman Coulter/Danaher
  Becton Dickinson
  Diagnostica Stago
  Grifols
  Helena Laboratories
  IL/Werfen
  Roche
  Sekisui Diagnostics
  Siemens Healthineers
  Sysmex
  Thermo Fisher, and others

List Of Tables

LIST OF TABLES

Egypt Coagulation Test Volume Forecasts by Procedure
Egypt Coagulation Diagnostics Market by Product Category
Ghana Coagulation Test Volume Forecasts by Procedure
Ghana Coagulation Diagnostics Market by Product Category
Kenya Coagulation Test Volume Forecasts by Procedure
Kenya Coagulation Diagnostics Market by Product Category
Morocco Coagulation Test Volume Forecasts by Procedure
Morocco Coagulation Diagnostics Market by Product Category
Nigeria Coagulation Test Volume Forecasts by Procedure
Nigeria Coagulation Diagnostics Market by Product Category
South Africa Coagulation Test Volume Forecasts by Procedure
South Africa Coagulation Diagnostics Market by Product Category